Atlas Trials

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Clinical trial NCT06011304 · UNKNOWN

Trial details

NCT number
NCT06011304
Sponsor
HTA Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2023-10-20
Primary completion
2024-11-01
Enrollment
267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.